Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3019% below fair value

$0.63−0.05 (-7.36%)

Close on Nov 13, 2026Market cap $66.74MP/E –Yield –

Hyperfine profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Hyperfine's profit margin for the twelve months ending Sep 30, 2026 was -156.4%. For fiscal 2025 it was -262.3%, against -315.9% the year before. The highest annual figure on record is -262.3% in fiscal 2025.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-262.3%	+53.6
FY2024	Dec 31, 2024	-315.9%	+85.1
FY2023	Dec 31, 2023	-401.0%	+248.2
FY2022	Dec 31, 2022	-649.2%	+3685.7
FY2021	Dec 31, 2021	-4335.0%	+3633.4
FY2020	Dec 31, 2020	-7968.4%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-100.4%	+220.2
Q2 FY2026	Jun 30, 2026	-238.2%	+104.0
Q1 FY2026	Mar 31, 2026	-220.9%	+219.8
Q4 FY2025	Dec 31, 2025	-111.7%	+336.0
Q3 FY2025	Sep 30, 2025	-320.6%	−37.2
Q2 FY2025	Jun 30, 2025	-342.2%	−62.5
Q1 FY2025	Mar 31, 2025	-440.7%	−141.8
Q4 FY2024	Dec 31, 2024	-447.7%	−49.9
Q3 FY2024	Sep 30, 2024	-283.4%	+178.2
Q2 FY2024	Jun 30, 2024	-279.7%	+34.9
Q1 FY2024	Mar 31, 2024	-298.9%	+162.6
Q4 FY2023	Dec 31, 2023	-397.8%	−1512.0
Q3 FY2023	Sep 30, 2023	-461.7%	+99.3
Q2 FY2023	Jun 30, 2023	-314.6%	+1196.1
Q1 FY2023	Mar 31, 2023	-461.5%	+1114.1
Q4 FY2022	Dec 31, 2022	1114.3%	+7097.1
Q3 FY2022	Sep 30, 2022	-560.9%	+3857.4
Q2 FY2022	Jun 30, 2022	-1510.7%	+2561.9
Q1 FY2022	Mar 31, 2022	-1575.5%	+779.1
Q4 FY2021	Dec 31, 2021	-5982.8%	–
Q3 FY2021	Sep 30, 2021	-4418.3%	–
Q2 FY2021	Jun 30, 2021	-4072.6%	–
Q1 FY2021	Mar 31, 2021	-2354.7%	–